9-5300138-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_134441.3(RLN2):āc.518A>Gā(p.His173Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000629 in 1,605,070 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_134441.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RLN2 | NM_134441.3 | c.518A>G | p.His173Arg | missense_variant | 2/2 | ENST00000381627.4 | NP_604390.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RLN2 | ENST00000381627.4 | c.518A>G | p.His173Arg | missense_variant | 2/2 | 1 | NM_134441.3 | ENSP00000371040.3 | ||
RLN2 | ENST00000416837 | c.*265A>G | 3_prime_UTR_variant | 3/3 | 3 | ENSP00000399616.1 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152218Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000371 AC: 9AN: 242330Hom.: 0 AF XY: 0.0000383 AC XY: 5AN XY: 130654
GnomAD4 exome AF: 0.0000633 AC: 92AN: 1452734Hom.: 0 Cov.: 31 AF XY: 0.0000692 AC XY: 50AN XY: 722150
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152336Hom.: 0 Cov.: 32 AF XY: 0.0000537 AC XY: 4AN XY: 74496
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 20, 2024 | The c.518A>G (p.H173R) alteration is located in exon 2 (coding exon 2) of the RLN2 gene. This alteration results from a A to G substitution at nucleotide position 518, causing the histidine (H) at amino acid position 173 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at